National Institute of Allergy and Infectious Diseases-Antimicrobial Resistance
Program Funding
Annual program obligations reported to SAM.gov.
Program Objective
Funding and conducting research to better understand how microbes develop and pass on resistance genes. Supporting the development of new and faster diagnostic tests to make it easier for doctors to prescribe the most effective drug. Research program also focuses on ways to prevent infections, including vaccines, and developing new antibiotics and novel treatments effective against drug-resistant microbes.
Eligibility
Eligible Applicants
- For-Profit Organization
- Not-for-Profit Organization
- U.S. State Government
- Federally Recognized Tribal Government
- Tribal Government (other)
- Tribally Designated Housing Authority
- Municipality/Township Government
- County Government
- School District Government
- Foreign For-Profit Organization
- Foreign Nonprofit Organization
How to Apply
Award Procedure
Applicants submit the grant application in grants.gov following guidance provided in the Notice of Funding Opportunity (NOFO). Center for Scientific Review (CSR) then assigns the application. A peer review process by Scientific Review Group (SRG) determines an overall impact score or percentile. A second level peer review is done by NIAID’s advisory council which determines if there is concurrence with the initial peer review, program relevance, and fiscal considerations. NIAID selects proposals based on several factors including scientific and technical merit, programmatic priorities/set-asides, and budget availability that fiscal year. The Council makes recommendations to NIAID leadership. After advisory council review NIAID program staff evaluates applications. NIAID officials under delegated HHS authority consider all factors and make funding decisions. The NIAID Grants Management Officer (GMO) issues a Notice of Award (NOA) and only the GMO has authority to obligate federal funds. The NOA is the legally binding document which obligates federal funds. The NOA specifies the approved budget period which is the specific time interval within the project period for which funds are provided.
Decision Timeline
- Approval: > 180 Days
- Renewal interval: > 180 Days
- Appeal: > 180 Days
Program details & compliance
Description
Understanding how microbes develop and transmit resistance genes. Developing new antibiotics and novel therapies. Creating faster and more accurate diagnostic tests. Supporting vaccines and preventive strategies.
Mission Categories
Primary: Biology
Other categories:
Research and Development
Required Documentation
Scientific merit of the proposed study. Assessing the importance/impact of the proposed study and its goals. Evaluating the quality of the experimental design and approach. The ability of the proposed investigator or research group to successfully execute the project. Examine whether the proposed resources, infrastructure, and institutional facilities are sufficient to support the project. Budgetary considerations are reviewed to determine the necessity of the components requested. This entails examining whether the proposed expenditures align well with the activities and scale of the project. Determining whether all items requested are essential for successful execution.
Reporting & Compliance
Applicable 2 CFR 200 Subparts
- Subpart B — General Provisions
- Subpart C — Pre-Federal Award Requirements
- Subpart D — Post-Federal Award Requirements
- Subpart E — Cost Principles
- Subpart F — Audit Requirements